Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
Author:
Franco Locatelli,Christine Mauz-Koerholz,Kathleen Neville,Anna Llort,Auke Beishuizen,Stephen Daw,Marta Pillon,Nathalie Aladjidi,Thomas Klingebiel,Judith Landman-Parker,Aurora Medina-Sanson,Keith August,Jessica Sachs,Kristen Hoffman,Judith Kinley et al.
Publication:
The Lancet Haematology
© 2018 Elsevier Ltd. All rights reserved.